Both in Pharmaceuticals
Sagimet Biosciences Inc. Series A vs Geron
Over the past year SGMT returned +16.4% and GERN returned −29.0%; their daily moves had a correlation of 0.25.
SGMT +16.4% GERN −29.0%Growth of $1, one year, split-adjusted
| Metric | SGMT | GERN |
|---|---|---|
| Price | $9.92 | $0.8944 |
| Market cap | $703.4M | $574.6M |
| Today | −4.89% | −5.47% |
| 1 month | +5.9% | −26.1% |
| 6 months | +30.4% | −43.4% |
| Year to date | +67.6% | −32.2% |
| 1 year | +19.1% | −27.3% |
| Revenue growth (YoY) | — | +17.2% |
| Gross margin | — | 83.9% |
| Net margin | — | −29.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.8× |
| Net cash | $240.1M | $51.1M |
| Dividend yield | — | — |
| Volatility (60d) | 73.9% | 60.1% |
| Short % of float | 21.2% | 11.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).